Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: Use of 24-hour gastric pH monitoring

American Journal of Gastroenterology

Volumn 95, Issue 2, 2000, Pages 374-380

  Ladas, Spiros D ^a   Tassios, Pericles S ^a   Raptis, Sotirios A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

ADULT; AGE; AGED; ARTICLE; ESOPHAGITIS; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PATIENT SELECTION; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; STOMACH PH;

ADULT; AGED; CONFIDENCE INTERVALS; ENZYME INHIBITORS; ESOPHAGITIS, PEPTIC; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROGEN-ION CONCENTRATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MONITORING, AMBULATORY; OMEPRAZOLE; PATIENT SELECTION; PROSPECTIVE STUDIES; RECURRENCE; REMISSION INDUCTION; SENSITIVITY AND SPECIFICITY; STOMACH; TREATMENT OUTCOME;

EID: 0033953053     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00815-1     Document Type: Article

References (33)

1. McDougall N.I., Johnston B.T., Kee F., et al. Natural history of reflux oesophagitis A 10 year follow up of its effect on patient symptomatology and quality of life. Gut. 38:1996;481-486
2. Locke G.R., Talley N.J., Fett S.L., et al. Prevalence and clinical spectrum of gastroesophageal reflux A population-based study in Olmsted country, Minnesota. Gastroenterology. 112:1997;1448-1456
3. Spechler S.J. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion. 51:(suppl):1992;24-29
4. Hetzel D.J., Dent J., Reed W.D., et al. Healing and relapse of severe peptic oesophagitis after treatment with omeprazole. Gastroenterology. 95:1988;903-912
5. Vigneri S., Termini R., Leandro G., et al. A comparison of five maintenance therapies for reflux oesophagitis. N Engl J Med. 333:1995;1106-1110
6. Hallerback B., Unge P., Carling L., et al. Omeprazole or ranitidine in long-term treatment of reflux oesophagitis. Gastroenterology. 107:1994;1305-1311
7. Dent J. Australian clinical trials of omeprazole in the management of reflux oesophagitis. Digestion. 47:(suppl 1):1990;69-71
8. Heudebert G.R., Marks R., Wilcox C.M., et al. Choice of long-term strategy for the management of patients with severe oesophagitis A cost-utility analysis. Gastroenterology. 112:1997;1078-1086
9. Klinkenberg-Knol E.C., Festen H.P.M., Jansen J.B.M.J., et al. Long-term treatment with omeprazole for refractory reflux oesophagitis. Efficacy and safety. Ann Intern Med. 121:1994;161-167
10. Lambers R., Creutzfeldt W., Struber H.G., et al. Long-term omeprazole therapy in peptic ulcer disease. Gastrin, endocrine cell growth and gastritis. Gastroenterology. 104:1993;1356-1370
11. Kuipers E.J., Lundell L., Klinkenberg-Knol E.C., et al. Atrophic gastritis and H. pylori infection in patients with reflux oesophagitis treated with omeprazole or fundopixation. N Engl J Med. 334:1996;1018-1022
12. Isal J.P., Zeitoun P., Barbier P., et al. Comparison of two dosage regimens of omeprazole - 10 mg once daily and 20 mg weekends - as prophylaxis against recurrence of reflux oesophagitis. Gastroenterology. 98:1990;A63. (abstract)
13. Dent J., Yeomans N.D., Mackinnon M., et al. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety. Gut. 35:1994;590-598
14. Kurucar C., Sontag S.J., Schnell T., et al. Can we predict which patients with severe gastroesophageal reflux will tolerate alternate day therapy with omeprazole? Gastroenterology. 110:1996;A165. (abstract)
15. 2RA) resistant reflux oesophagitis. Gastroenterology. 100:1991;A29. (abstract)
16. Bate C.M., Booth S.N., Crowe J.P., et al. Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Gut. 36:1995;492-498
17. Robinson M., Lanza F., Avner D., et al. Effective maintenance treatment of reflux oesophagitis with low-dose lansoprazole. A randomized, double-blind, placebo-controlled trial. Ann Inter Med. 124:1996;859-867
18. Bardhan K.D., Cherian P., Vaishnavi A., et al. Erosive oesophagitis Outcome of repeated long term maintenance treatment with low dose omeprazole 10 mg or placebo. Gut. 43:1998;458-464
19. Ligumsky M., Siguencia J., Lysy J. Omeprazole related hypergastrinemia Effect of long-term daily versus alternate day therapy. Gastroenterology. 108:1995;A152. (abstract)
20. Savary M., Miller G. The oesophagus. Handbook and atlas of endoscopy. 1978;119-205 Verlag Gassman AG, Solothurn, Switzerland
21. Maratka Z. Terminology, definitions and diagnostic criteria in digestive endoscopy, 2nd ed. 1994;Normed-Verlag, Bad Homburg, Germany
22. Verdu E.F., Armstrong D., Frazer R., et al. Effect of H. pylori status on intragastric pH during treatment with omeprazole. Gut. 36:1995;539-542
23. Clinical oesophageal pH recording A technical review for practice guideline development. Gastroenterology. 110:1996;1982-1996
24. Bell N.J.V., Burget D., Howden C.W., et al. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion. 51:(suppl 1):1995;59-67
25. nd ed. 1987;713-722 Blackwell, London
26. Sloan S., Rademaker A.W., Kahrilas P.J. Determinants of gastroesophageal junction incompetence Hiatal hernia, lower oesophageal sphincter, or both. Ann Intern Med. 117:1992;977-982
27. Johnsson F., Joelsson B., Isberg P.E. Ambulatory 24-hour intra-oesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut. 28:1987;1145-1150
28. Kasapidis P., Xynos E., Mantides A., et al. Differences in manometry and 24-hour ambulatory pH-metry between patients with and without endoscopic or histologic oesophagitis in gastroesophageal reflux disease. Am J Gastroenterol. 88:1993;1893-1899
29. Johnson L.F., DeMeester T.R. Development of the 24-hour pH monitoring composite scoring system. J Clin Gastroenterol. 8:1995;52-58
30. Hunt R.H., Cederberg C., Dent J., et al. Optimizing acid suppression for treatment of acid-related diseases. Dig Dis Science 40:(suppl):1995;24S-29S
31. DeVault K.R., Castell D.O. Guidelines of the diagnosis and treatment of gastroesophageal reflux disease. Arch Intern Med. 155:1995;2165-2173
32. Hendel J., Hendel L., Hage E., et al. Monitoring of omeprazole treatment in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol. 8:1996;417-420
33. Leite L.P., Johnston B.T., Just R.J., et al. Persistent acid secretion during omeprazole therapy. A study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol. 91:1996;1527-1531